Reply: Potential role of Janus kinase inhibitors in COVID-19

Maddalena Napolitano, Gabriella Fabbrocini, Cataldo Patruno

2020Journal of the American Academy of Dermatology22 citationsDOI Open Access PDF

Topics & Concepts

MedicineJanus kinaseRuxolitinibDiscontinuationImmunologyVirologyInternal medicineCytokineBone marrowMyelofibrosisSARS-CoV-2 and COVID-19 ResearchInflammasome and immune disordersDermatology and Skin Diseases